p53 Protects lung cancer cells against metabolic stress

Chompunoot Sinthupibulyakit1, Wanida Ittarat, William H St Clair

  • 1Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.

Insights

The glycolytic inhibitor 2-deoxy-D-glucose (2DG) shows cytotoxicity in non-small cell lung cancer cells. This effect is p53-dependent, with p53-deficient cells being more susceptible to 2DG treatment.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Biology

Background:

  • The Warburg effect, preferential aerobic glycolysis in cancer, is a therapeutic target.
  • The efficacy of inhibiting glycolysis across all cancer types remains uncertain.

Purpose of the Study:

  • To investigate the cytotoxic effect of the glycolytic inhibitor 2-deoxy-D-glucose (2DG) on non-small cell lung cancer (NSCLC).
  • To determine the role of p53 in mediating the response to 2DG in NSCLC.

Main Methods:

  • Treatment of p53-deficient (H358) and p53-wild-type (A549) NSCLC cells with 2DG.
  • Assessment of ATP production and oxidative phosphorylation (OXPHOS) capacity.
  • Analysis of reactive oxygen species (ROS) levels and expression of p53 target genes and antioxidant enzymes.

Main Results:

  • 2DG significantly inhibited ATP production in p53-deficient cells but not in p53-wild-type cells.
  • p53-wild-type cells compensated for inhibited glycolysis via OXPHOS, unlike p53-deficient cells.
  • p53-dependent induction of antioxidant enzymes (MnSOD, GPx1) and metabolic regulators (SCO2, TIGAR) was observed.

Conclusions:

  • The cytotoxic effect of 2DG is more efficient in cancer cells lacking functional p53.
  • p53 protects cancer cells against metabolic stress induced by glycolytic inhibition through enhanced OXPHOS and antioxidant defense.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...